- Report
- June 2024
- 140 Pages
Africa, Middle East
From €3429EUR$3,869USD£2,953GBP
- Report
- June 2024
- 140 Pages
Latin America
From €3429EUR$3,869USD£2,953GBP
- Report
- June 2024
- 140 Pages
Europe
From €3429EUR$3,869USD£2,953GBP
- Report
- April 2024
- 140 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- February 2024
- 180 Pages
Global
From €4403EUR$4,969USD£3,792GBP
- Report
- February 2024
- 180 Pages
Global
From €4403EUR$4,969USD£3,792GBP
- Report
- September 2023
- 200 Pages
Global
From €3189EUR$3,599USD£2,747GBP
- Report
- September 2023
- 160 Pages
Global
From €3189EUR$3,599USD£2,747GBP
- Report
- April 2023
- 147 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- April 2023
- 147 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- April 2023
- 147 Pages
Global
From €4386EUR$4,949USD£3,777GBP
- Report
- December 2023
- 171 Pages
Global
From €3545EUR$4,000USD£3,053GBP
- Report
- October 2023
- 259 Pages
Global
From €3545EUR$4,000USD£3,053GBP
- Report
- September 2023
- 50 Pages
Global
From €2215EUR$2,500USD£1,908GBP
- Report
- February 2024
- 128 Pages
Asia Pacific
From €3057EUR$3,450USD£2,633GBP
- Report
- December 2023
- 116 Pages
Middle East, Africa
From €3057EUR$3,450USD£2,633GBP
- Report
- December 2023
- 115 Pages
North America
From €3057EUR$3,450USD£2,633GBP
- Report
- December 2023
- 122 Pages
Europe
From €3057EUR$3,450USD£2,633GBP
- Report
- February 2023
- 143 Pages
North America
From €3057EUR$3,450USD£2,633GBP
- Report
- February 2023
- 128 Pages
From €3057EUR$3,450USD£2,633GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more